Filed under Bayer’s patented drug

Genetically Engineered Crop Patents – Economic Times Publication – “Monsanto’s Climate Resilient Crop Patent Rejection by IPAB”

Genetically Engineered Crop Patents – Economic Times Publication – “Monsanto’s Climate Resilient Crop Patent Rejection by IPAB”

Original Source of Article: http://wp.me/p2PCVq-LX Recently, our views were published in The Economic Times regarding Monsanto’s patent rejection order passed by Intellectual Property Appellate Board (IPAB). A copy of order may be seen here: Intellectual Property Appellate Board, Chennai – Orders – Monsanto  A copy of Monsanto’s International Patent publication titled “Methods for enhancing stress tolerance in … Continue reading

India Allows Compulsory Licensing Of Bayer's Anti-Cancer Drug Sorafenib To NATCO Pharma

India Allows Compulsory Licensing Of Bayer’s Anti-Cancer Drug Sorafenib To NATCO Pharma Article Source: http://techcorplegal.com/Startup_Business/Blog/compulsory_license_india.html Full Article: http://techcorplegal.com/Articles/compulsory_licensing_india.pdf HTML Version: http://biospectrumindia.ciol.com/content/newsAnalysis/11204091.asp Recently, expert opinion of Advocate Rahul Dev, Bioscience Business Lawyer & Patent Attorney, was published in cover story of BioSpectrum India. The globally watched case related to an Indian pharma company’s request to the … Continue reading